327 related articles for article (PubMed ID: 32911658)
1. The Pathophysiological Significance of Fibulin-3.
Livingstone I; Uversky VN; Furniss D; Wiberg A
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32911658
[TBL] [Abstract][Full Text] [Related]
2. Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family.
Zhang K; Sun X; Chen Y; Zhong Q; Lin L; Gao Y; Hong F
BMC Ophthalmol; 2018 Dec; 18(1):318. PubMed ID: 30541486
[TBL] [Abstract][Full Text] [Related]
3. Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy: Similarities to Age-Related Macular Degeneration and Potential Therapies.
Hulleman JD
Adv Exp Med Biol; 2016; 854():153-8. PubMed ID: 26427406
[TBL] [Abstract][Full Text] [Related]
4. Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration.
Garland DL; Fernandez-Godino R; Kaur I; Speicher KD; Harnly JM; Lambris JD; Speicher DW; Pierce EA
Hum Mol Genet; 2014 Jan; 23(1):52-68. PubMed ID: 23943789
[TBL] [Abstract][Full Text] [Related]
5. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice.
McLaughlin PJ; Bakall B; Choi J; Liu Z; Sasaki T; Davis EC; Marmorstein AD; Marmorstein LY
Hum Mol Genet; 2007 Dec; 16(24):3059-70. PubMed ID: 17872905
[TBL] [Abstract][Full Text] [Related]
6. Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.
Zhang T; Xie X; Cao G; Jiang H; Wu S; Su Z; Zhang K; Lu F
Retina; 2014 Dec; 34(12):2462-71. PubMed ID: 25111685
[TBL] [Abstract][Full Text] [Related]
7. First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.
Sheyanth IN; Lolas IB; Okkels H; Kiruparajan LP; Abildgaard SK; Petersen MB
Mol Genet Genomic Med; 2021 Apr; 9(4):e1652. PubMed ID: 33689237
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration.
Guymer RH; McNeil R; Cain M; Tomlin B; Allen PJ; Dip CL; Baird PN
Clin Exp Ophthalmol; 2002 Dec; 30(6):419-23. PubMed ID: 12427233
[TBL] [Abstract][Full Text] [Related]
9. Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review.
Marmorstein L
Ophthalmic Genet; 2004 Sep; 25(3):219-26. PubMed ID: 15512998
[TBL] [Abstract][Full Text] [Related]
10. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.
Fu L; Garland D; Yang Z; Shukla D; Rajendran A; Pearson E; Stone EM; Zhang K; Pierce EA
Hum Mol Genet; 2007 Oct; 16(20):2411-22. PubMed ID: 17666404
[TBL] [Abstract][Full Text] [Related]
11. Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration.
Tsai YT; Li Y; Ryu J; Su PY; Cheng CH; Wu WH; Li YS; Quinn PMJ; Leong KW; Tsang SH
Am J Hum Genet; 2021 May; 108(5):903-918. PubMed ID: 33909993
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations.
Klenotic PA; Munier FL; Marmorstein LY; Anand-Apte B
J Biol Chem; 2004 Jul; 279(29):30469-73. PubMed ID: 15123717
[TBL] [Abstract][Full Text] [Related]
13. Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.
Driver SGW; Jackson MR; Richter K; Tomlinson P; Brockway B; Halliday BJ; Markie DM; Robertson SP; Wade EM
Eur J Hum Genet; 2020 Apr; 28(4):445-452. PubMed ID: 31792352
[TBL] [Abstract][Full Text] [Related]
14. EFEMP1 is not associated with sporadic early onset drusen.
Sauer CG; White K; Kellner U; Rudolph G; Jurklies B; Pauleikhoff D; Weber BH
Ophthalmic Genet; 2001 Mar; 22(1):27-34. PubMed ID: 11262647
[TBL] [Abstract][Full Text] [Related]
15. Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity.
Daniel S; Renwick M; Chau VQ; Datta S; Maddineni P; Zode G; Wade EM; Robertson SP; Petroll WM; Hulleman JD
J Mol Med (Berl); 2020 Nov; 98(11):1639-1656. PubMed ID: 32964303
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the EFEMP1 gene in individuals and families with early onset drusen.
Narendran N; Guymer RH; Cain M; Baird PN
Eye (Lond); 2005 Jan; 19(1):11-5. PubMed ID: 15218514
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Efemp1 Is Protective Against the Development of Sub-RPE Deposits in Mouse Eyes.
Stanton JB; Marmorstein AD; Zhang Y; Marmorstein LY
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1455-1461. PubMed ID: 28264101
[TBL] [Abstract][Full Text] [Related]
18. Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.
Hulleman JD; Kaushal S; Balch WE; Kelly JW
Mol Biol Cell; 2011 Dec; 22(24):4765-75. PubMed ID: 22031286
[TBL] [Abstract][Full Text] [Related]
19. The second Japanese family with Malattia Leventinese/Doyne honeycomb retinal dystrophy.
Enomoto N; Hayashi T; Matsuura T; Tanaka K; Takeuchi R; Tomita G; Mori R
Doc Ophthalmol; 2022 Feb; 144(1):67-75. PubMed ID: 34822027
[TBL] [Abstract][Full Text] [Related]
20. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.
Stone EM; Lotery AJ; Munier FL; Héon E; Piguet B; Guymer RH; Vandenburgh K; Cousin P; Nishimura D; Swiderski RE; Silvestri G; Mackey DA; Hageman GS; Bird AC; Sheffield VC; Schorderet DF
Nat Genet; 1999 Jun; 22(2):199-202. PubMed ID: 10369267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
